{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:21:04Z","timestamp":1773296464897,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.virusres.2007.03.025","type":"journal-article","created":{"date-parts":[[2007,5,12]],"date-time":"2007-05-12T11:13:13Z","timestamp":1178968393000},"page":"20-32","source":"Crossref","is-referenced-by-count":123,"title":["Animal models and vaccines for SARS-CoV infection"],"prefix":"10.1016","volume":"133","author":[{"given":"Anjeanette","family":"Roberts","sequence":"first","affiliation":[]},{"given":"Elaine W.","family":"Lamirande","sequence":"additional","affiliation":[]},{"given":"Leatrice","family":"Vogel","sequence":"additional","affiliation":[]},{"given":"Jadon P.","family":"Jackson","sequence":"additional","affiliation":[]},{"given":"Christopher D.","family":"Paddock","sequence":"additional","affiliation":[]},{"given":"Jeannette","family":"Guarner","sequence":"additional","affiliation":[]},{"given":"Sherif R.","family":"Zaki","sequence":"additional","affiliation":[]},{"given":"Timothy","family":"Sheahan","sequence":"additional","affiliation":[]},{"given":"Ralph","family":"Baric","sequence":"additional","affiliation":[]},{"given":"Kanta","family":"Subbarao","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.virusres.2007.03.025_bib1","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.virusres.2007.03.025_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2005.01.042","article-title":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein","volume":"334","author":"Bisht","year":"2005","journal-title":"Virology"},{"issue":"26","key":"10.1016\/j.virusres.2007.03.025_bib3","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1073\/pnas.0403492101","article-title":"Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity","volume":"101","author":"Buchholz","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9427","key":"10.1016\/j.virusres.2007.03.025_bib4","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(04)16501-X","article-title":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS","volume":"363","author":"Bukreyev","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.virusres.2007.03.025_bib5","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/JVI.79.5.2678-2688.2005","article-title":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.03.025_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1023\/B:DOBS.0000039701.92375.b6","article-title":"Symptoms of infection caused by SARS coronavirus in laboratory mice and guinea pigs","volume":"397","author":"Chepurnov","year":"2004","journal-title":"Dokl. Biol. Sci."},{"issue":"7","key":"10.1016\/j.virusres.2007.03.025_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0264-410X(92)90397-3","article-title":"Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia\u2014RSV recombinants or RSV","volume":"10","author":"Connors","year":"1992","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.virusres.2007.03.025_bib8","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.66.12.7444-7451.1992","article-title":"Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of CD4+ T cells","volume":"66","author":"Connors","year":"1992","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virusres.2007.03.025_bib9","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1128\/JVI.66.11.6695-6705.1992","article-title":"Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus","volume":"66","author":"Corapi","year":"1992","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2007.03.025_bib10","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/JVI.69.5.2858-2862.1995","article-title":"Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement","volume":"69","author":"Corapi","year":"1995","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virusres.2007.03.025_bib11","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants","volume":"3","author":"Deming","year":"2006","journal-title":"PLoS Med."},{"issue":"Pt 5","key":"10.1016\/j.virusres.2007.03.025_bib12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"Faber","year":"2005","journal-title":"J. Gen. Virol."},{"issue":"6937","key":"10.1016\/j.virusres.2007.03.025_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/423240a","article-title":"Aetiology: Koch's postulates fulfilled for SARS virus","volume":"423","author":"Fouchier","year":"2003","journal-title":"Nature"},{"issue":"9399","key":"10.1016\/j.virusres.2007.03.025_bib14","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(03)14962-8","article-title":"Effects of a SARS-associated coronavirus vaccine in monkeys","volume":"362","author":"Gao","year":"2003","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.virusres.2007.03.025_bib15","first-page":"1199","article-title":"Infection of SARS-CoV on juvenile and adult Brandt's vole","volume":"50","author":"Gao","year":"2005","journal-title":"Chinese Sci. Bull."},{"issue":"6","key":"10.1016\/j.virusres.2007.03.025_bib16","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.4049\/jimmunol.173.6.4030","article-title":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice","volume":"173","author":"Glass","year":"2004","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.virusres.2007.03.025_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/427242","article-title":"Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice","volume":"191","author":"Greenough","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virusres.2007.03.025_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9440(10)62989-6","article-title":"Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus","volume":"167","author":"Greenough","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.virusres.2007.03.025_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv. Virus. Res."},{"issue":"10","key":"10.1016\/j.virusres.2007.03.025_bib20","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.4049\/jimmunol.176.10.6085","article-title":"Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein","volume":"176","author":"He","year":"2006","journal-title":"J. Immunol."},{"issue":"20","key":"10.1016\/j.virusres.2007.03.025_bib21","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1128\/JVI.78.20.11416-11421.2004","article-title":"Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1","volume":"78","author":"Hogan","year":"2004","journal-title":"J. Virol."},{"issue":"3\u20134","key":"10.1016\/j.virusres.2007.03.025_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01310476","article-title":"A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies","volume":"120","author":"Hohdatsu","year":"1991","journal-title":"Arch. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2007.03.025_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1348-0421.1993.tb03242.x","article-title":"Enhancement and neutralization of feline infectious peritonitis virus infection in feline macrophages by neutralizing monoclonal antibodies recognizing different epitopes","volume":"37","author":"Hohdatsu","year":"1993","journal-title":"Microbiol. Immunol."},{"issue":"3","key":"10.1016\/j.virusres.2007.03.025_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/167.3.553","article-title":"A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine","volume":"167","author":"Kakuk","year":"1993","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2007.03.025_bib25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.vaccine.2006.08.011","article-title":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro","volume":"25","author":"Kam","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virusres.2007.03.025_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","article-title":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine","volume":"340","author":"Kapadia","year":"2005","journal-title":"Virology"},{"issue":"9380","key":"10.1016\/j.virusres.2007.03.025_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(03)13967-0","article-title":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","volume":"362","author":"Kuiken","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.virusres.2007.03.025_bib28","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1371\/journal.pmed.0030149","article-title":"Cynomolgus macaque as an animal model for severe acute respiratory syndrome","volume":"3","author":"Lawler","year":"2006","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.virusres.2007.03.025_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1386-6532(03)00195-1","article-title":"SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients","volume":"28","author":"Li","year":"2003","journal-title":"J. Clin. Virol."},{"issue":"6961","key":"10.1016\/j.virusres.2007.03.025_bib30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/425915a","article-title":"Virology: SARS virus infection of cats and ferrets","volume":"425","author":"Martina","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virusres.2007.03.025_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virol.2004.09.030","article-title":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys","volume":"330","author":"McAuliffe","year":"2004","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.virusres.2007.03.025_bib32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0264-410X(90)90253-I","article-title":"Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3\u20136 months after immunization","volume":"8","author":"Murphy","year":"1990","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virusres.2007.03.025_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/JVI.66.2.956-965.1992","article-title":"Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages","volume":"66","author":"Olsen","year":"1992","journal-title":"J. Virol."},{"issue":"Pt 4","key":"10.1016\/j.virusres.2007.03.025_bib34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1099\/0022-1317-74-4-745","article-title":"Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity","volume":"74","author":"Olsen","year":"1993","journal-title":"J. Gen. Virol."},{"issue":"Pt 10","key":"10.1016\/j.virusres.2007.03.025_bib35","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1099\/vir.0.80111-0","article-title":"Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine","volume":"85","author":"Pang","year":"2004","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2007.03.025_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/path.1769","article-title":"An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus","volume":"206","author":"Qin","year":"2005","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.virusres.2007.03.025_bib37","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.vaccine.2005.06.038","article-title":"Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine","volume":"24","author":"Qin","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.virusres.2007.03.025_bib38","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.vaccine.2004.07.031","article-title":"Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice","volume":"23","author":"Qu","year":"2005","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.virusres.2007.03.025_bib39","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1128\/JVI.79.9.5833-5838.2005","article-title":"Aged BALB\/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans","volume":"79","author":"Roberts","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2007.03.025_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/JVI.79.1.503-511.2005","article-title":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters","volume":"79","author":"Roberts","year":"2005","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2007.03.025_bib41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/500143","article-title":"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters","volume":"193","author":"Roberts","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"49\u201350","key":"10.1016\/j.virusres.2007.03.025_bib42","doi-asserted-by":"crossref","first-page":"7056","DOI":"10.1016\/j.vaccine.2006.07.009","article-title":"Animal models and antibody assays for evaluating candidate SARS vaccines: summary of a technical meeting, August 25\u201326, 2005, London, UK","volume":"24","author":"Roberts","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virusres.2007.03.025_bib43","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1371\/journal.ppat.0030005","article-title":"Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB\/c Mice","volume":"3","author":"Roberts","year":"2007","journal-title":"PLoS Pathog."},{"issue":"20","key":"10.1016\/j.virusres.2007.03.025_bib44","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1128\/JVI.78.20.11401-11404.2004","article-title":"Macaque model for severe acute respiratory syndrome","volume":"78","author":"Rowe","year":"2004","journal-title":"J. Virol."},{"issue":"Pt 3","key":"10.1016\/j.virusres.2007.03.025_bib45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1099\/vir.0.81579-0","article-title":"Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus","volume":"87","author":"See","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2007.03.025_bib46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.vaccine.2005.08.055","article-title":"A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses","volume":"24","author":"Spruth","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.virusres.2007.03.025_bib47","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3201\/eid1108.041003","article-title":"SARS vaccine protective in mice","volume":"11","author":"Stadler","year":"2005","journal-title":"Emerg. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virusres.2007.03.025_bib48","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virusres.2007.03.025_bib49","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/j.virusres.2007.03.025_bib50","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1128\/JVI.79.10.5900-5906.2005","article-title":"Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants","volume":"79","author":"Sui","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.03.025_bib51","first-page":"145","article-title":"Antibody-mediated enhancement of viral disease","volume":"260","author":"Sullivan","year":"2001","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"10","key":"10.1016\/j.virusres.2007.03.025_bib52","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/intimm\/dxh143","article-title":"A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice","volume":"16","author":"Takasuka","year":"2004","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.virusres.2007.03.025_bib53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/104454904323145272","article-title":"Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB\/c mice","volume":"23","author":"Tang","year":"2004","journal-title":"DNA Cell Biol."},{"issue":"9427","key":"10.1016\/j.virusres.2007.03.025_bib54","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","article-title":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets","volume":"363","author":"ter Meulen","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.virusres.2007.03.025_bib55","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"ter Meulen","year":"2006","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.virusres.2007.03.025_bib56","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.virusres.2007.03.025_bib57","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/JVI.64.3.1407-1409.1990","article-title":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization","volume":"64","author":"Vennema","year":"1990","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2007.03.025_bib58","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JVI.79.3.1906-1910.2005","article-title":"Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2007.03.025_bib59","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/135965350501000504","article-title":"Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody","volume":"10","author":"Wang","year":"2005","journal-title":"Antivir. Ther."},{"issue":"1","key":"10.1016\/j.virusres.2007.03.025_bib60","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbrc.2004.11.147","article-title":"Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB\/c mice","volume":"327","author":"Wang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"10.1016\/j.virusres.2007.03.025_bib61","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2007.03.025_bib62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3201\/eid1002.030677","article-title":"Susceptibility of pigs and chickens to SARS coronavirus","volume":"10","author":"Weingartl","year":"2004","journal-title":"Emerg. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virusres.2007.03.025_bib63","first-page":"2036","article-title":"Pathogenesis of feline infetious peritonitis: pathologic changes and immunofluorescence","volume":"42","author":"Weiss","year":"1981","journal-title":"Am. J. Vet. Res."},{"issue":"42","key":"10.1016\/j.virusres.2007.03.025_bib64","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1016\/j.vaccine.2005.05.023","article-title":"SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus","volume":"23","author":"Woo","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virusres.2007.03.025_bib65","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/JVI.79.4.2620-2625.2005","article-title":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates","volume":"79","author":"Wu","year":"2005","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2007.03.025_bib66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.imlet.2004.06.014","article-title":"Immunogenicity of SARS inactivated vaccine in BALB\/c mice","volume":"95","author":"Xiong","year":"2004","journal-title":"Immunol. Lett."},{"issue":"6982","key":"10.1016\/j.virusres.2007.03.025_bib67","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virusres.2007.03.025_bib68","first-page":"60","article-title":"Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome","volume":"4","author":"Yang","year":"2005","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"3","key":"10.1016\/j.virusres.2007.03.025_bib69","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1073\/pnas.0409065102","article-title":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses","volume":"102","author":"Yang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.virusres.2007.03.025_bib70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virusres.2004.09.004","article-title":"SARS-coronavirus replication in human peripheral monocytes\/macrophages","volume":"107","author":"Yilla","year":"2005","journal-title":"Virus Res."},{"issue":"35","key":"10.1016\/j.virusres.2007.03.025_bib71","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/j.vaccine.2005.04.011","article-title":"Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines","volume":"23","author":"Zakhartchouk","year":"2005","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.virusres.2007.03.025_bib72","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1128\/JVI.78.13.6938-6945.2004","article-title":"Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.03.025_bib73","unstructured":"Zhang, Y., Yang, F., Li, Y.H., Li, W.H., Tu, X.M., Wei, Q., Zhu, H., Liu, L., Wang, H., Qin, C., Yuan, G.Y., He, W., Wang, S.H., 2004. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 18 (3), 258\u2013260."},{"issue":"24","key":"10.1016\/j.virusres.2007.03.025_bib74","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1016\/j.vaccine.2004.11.073","article-title":"Immune responses in BALB\/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain","volume":"23","author":"Zhang","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virusres.2007.03.025_bib75","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jmv.20431","article-title":"A serological survey on neutralizing antibody titer of SARS convalescent sera","volume":"77","author":"Zhang","year":"2005","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2007.03.025_bib76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/abbs\/36.1.37","article-title":"DNA vaccine of SARS-CoV S gene induces antibody response in mice","volume":"36","author":"Zhao","year":"2004","journal-title":"Acta. Biochim. Biophys. Sin. (Shanghai)"},{"issue":"13","key":"10.1016\/j.virusres.2007.03.025_bib77","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1128\/JVI.78.13.7217-7226.2004","article-title":"An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies","volume":"78","author":"Zhou","year":"2004","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virusres.2007.03.025_bib78","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1016\/j.vaccine.2004.11.075","article-title":"Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys","volume":"23","author":"Zhou","year":"2005","journal-title":"Vaccine"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817020700113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817020700113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T20:18:06Z","timestamp":1683836286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016817020700113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S016817020700113X"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2007.03.025","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}